Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.
(165)| Volume 32, ISSUE 4, SUPPLEMENT , S68, April 2013

Transmyocardial Revascularization Enhances Mesenchymal Stem Cell Engraftment in Infarcted Hearts through SCF–c-Kit and SDF-1–CXCR4 Signaling Axes

  • U. Shahzad
    Affiliations
    Department of Cardiovascular Surgery, University of Toronto, Toronto, ON, Canada

    Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada
    Search for articles by this author
  • G. Li
    Affiliations
    Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada
    Search for articles by this author
  • T.M. Yau
    Affiliations
    Department of Cardiovascular Surgery, University of Toronto, Toronto, ON, Canada

    Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, University Health Network, Toronto, ON, Canada
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Purpose

      We investigated the roles of stem cell factor(SCF)–c-kit and stromal derived factor-1(SDF-1)–chemokine receptor type 4(CXCR4) stem cell signaling axes in transmyocardial revascularization (TMR)-enhanced engraftment of transplanted mesenchymal stem cells (MSC) in infarcted hearts.

      Methods and Materials

      3 weeks after LAD ligation, female Lewis rats underwent 10-channel needle TMR, followed by daily IV injections of 1 million male donor MSC for 5 days, either wild type (WT) or with knockdown (K/D) of c-kit or CXCR4, accomplished via a shRNA+plasmid in a lentiviral vector. Experimental groups included: WT MSC with or without TMR, c-kit K/D MSC with or without TMR, and CXCR4 K/D MSC with or without TMR (N=6/group).

      Results

      In vitro cell surface expression of c-kit (N=3) was reduced from 14±0.7% of WT MSC to 1.6±0.4% c-kit K/D MSC, and CXCR4 (N=3) was reduced from 39±10% WT MSCs to 3.7±0.7% CXCR4 K/D MSC after 1 week (p<0.05). The number of MSCs that had homed into infarct was affected by both TMR and donor cell type at 3 days(TMR, cell type, & interaction, p<0.05) and 1 week (TMR & cell type, p<0.05) after the last MSC injection, with greater MSC engraftment with TMR and with WT MSC. At 3 days, TMR significantly upregulated in vivo transcription of c-kit (TMR, p<0.05), SCF (TMR & cell type, p<0.05), CXCR4 (TMR & cell type, p<0.05), and SDF-1 (TMR & cell type, p<0.05). At 1 week, we saw similar declines in expression of c-kit (cell type, p<0.05), SCF (TMR, p<0.05), CXCR4 (TMR & cell type, p<0.05), and SDF-1 (TMR, p<0.05). At 1 week, TMR improved LVEF (N=5) when WT MSCs were infused, but K/D of either c-kit or CXCR4 completely abrogated this TMR-mediated augmentation of MSC reparative effect (TMR & cell type, p<0.05).

      Conclusions

      Downregulation of either c-kit or CXCR4 in MSC decreased engraftment of circulating MSC and inhibited the reparative effects of TMR. Hence, both SCF–c-kit and SDF-1–CXCR4 signaling axes are required for TMR-augmented repair of the infarcted heart.